Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1D simulation study

Juan F Gomez1, Karen Cardona1, Lucia Romero1

  • 1Instituto de Investigación en Ingeniería Biomédica, Universitat Politècnica de València, Valencia, Spain.

Plos One
|September 6, 2014
PubMed

Insights

Heart failure remodeling significantly alters electrical properties, increasing arrhythmia risk. Fibrosis and uncoupling worsen these changes, impacting conduction and repolarization in the failing heart.

Area of Science:

  • Cardiovascular Physiology
  • Computational Biology
  • Cardiac Electrophysiology

Background:

  • Heart failure is a common pathway for cardiac diseases, often leading to sudden cardiac death due to ventricular arrhythmias.
  • Key arrhythmogenic factors include electrophysiological remodeling, intercellular uncoupling, fibrosis, and autonomic imbalance.

Purpose of the Study:

  • To investigate the in silico effects of electrophysiological and structural remodeling in heart failure on arrhythmogenic substrates.
  • To analyze the modulation of electrophysiological gradients and abnormal impulse propagation in failing ventricles.

Main Methods:

  • Utilized two mathematical models of human ventricular action potentials to create failing myocyte models.
  • Simulated electrical activity in a transmural ventricular strand to study remodeling effects.

Main Results:

  • Heterogeneous remodeling, particularly of the Na+/Ca2+ exchanger and SERCA pump, reduced repolarization heterogeneities.
  • Fibroblast proliferation and cellular uncoupling significantly increased repolarization heterogeneities.
  • Progressive structural remodeling reduced conduction velocity and the safety factor for conduction.

Conclusions:

  • Electrophysiological remodeling significantly alters ventricular repolarization gradients as heart failure progresses.
  • Enhanced fibrosis and reduced intercellular coupling in failing hearts increase electrophysiological gradients and impair electrical propagation, promoting arrhythmias.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.6K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
595